- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 and the role of cytokines in this disease
Authors
Keywords
-
Journal
INFLAMMOPHARMACOLOGY
Volume 30, Issue 3, Pages 789-798
Publisher
Springer Science and Business Media LLC
Online
2022-05-04
DOI
10.1007/s10787-022-00992-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting cyclooxygenase enzyme for the adjuvant COVID ‐19 therapy
- (2021) Parteek Prasher et al. DRUG DEVELOPMENT RESEARCH
- In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
- (2021) Linda Petrone et al. JOURNAL OF INFECTION
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- Profound dysregulation of T cell homeostasisand function in patients with severe COVID‐19
- (2021) Sarah Adamo et al. ALLERGY
- Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
- (2021) Corrado Pelaia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Baricitinib: From Rheumatoid Arthritis to COVID‐19 5
- (2021) Sara Assadiasl et al. JOURNAL OF CLINICAL PHARMACOLOGY
- IL-6 modulation for COVID-19: the right patients at the right time?
- (2021) Paolo Antonio Ascierto et al. Journal for ImmunoTherapy of Cancer
- Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
- (2021) Ali A. Rabaan et al. Vaccines
- The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease
- (2021) Don A. Davies et al. MOLECULAR NEUROBIOLOGY
- IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant
- (2021) Yonas Bekele et al. Frontiers in Immunology
- Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19
- (2021) Wei-Xi Shen et al. Frontiers in Public Health
- Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study
- (2021) Sergey N. Avdeev et al. CYTOKINE
- Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
- (2021) Evdoxia Kyriazopoulou et al. Lancet Rheumatology
- Conversion of effector CD4+ T cells to a CD8+ MHC II-recognizing lineage
- (2020) Elizabeth Robins et al. Cellular & Molecular Immunology
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Granulocyte‐colony stimulating factor in COVID ‐19: Is it stimulating more than just the bone marrow?
- (2020) Tamara Nawar et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
- (2020) Shengyu Zhang et al. CLINICAL DRUG INVESTIGATION
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
- (2020) Valentina Morena et al. European Journal of Internal Medicine
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Covid-19: what treatments are being investigated?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
- (2020) Marta Colaneri et al. Microorganisms
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
- (2020) Bakiye Goker Bagca et al. CYTOKINE & GROWTH FACTOR REVIEWS
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- COVID-19: Melatonin as a potential adjuvant treatment
- (2020) Rui Zhang et al. LIFE SCIENCES
- Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review
- (2020) Kaviyarasi Renu et al. LIFE SCIENCES
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Targeting the interleukin‐17 pathway to prevent acute respiratory distress syndrome associated with SARS‐CoV ‐2 infection
- (2020) Tomas Raul Wiche Salinas et al. RESPIROLOGY
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series
- (2020) Iris Navarro‐Millán et al. Arthritis & Rheumatology
- Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease
- (2020) Yan Zhao et al. JCI Insight
- The laboratory tests and host immunity of COVID-19 patients with different severity of illness
- (2020) Feng Wang et al. JCI Insight
- Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
- (2020) Pierre Francois Laterre et al. JAMA Network Open
- Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action
- (2020) Hassan Yousefi et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment
- (2020) Swamy Yeleswaram et al. CLINICAL IMMUNOLOGY
- Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
- (2020) Barnaby E Young et al. CLINICAL INFECTIOUS DISEASES
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- (2020) Francesco Perrone et al. Journal of Translational Medicine
- Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin
- (2020) Negin Mozafari et al. MEDICAL HYPOTHESES
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
- (2020) Prabhu S. Arunachalam et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Cytokine Storm
- (2020) David C. Fajgenbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Potential Role of Interleukin 10 in COVID-19 Pathogenesis
- (2020) Ligong Lu et al. TRENDS IN IMMUNOLOGY
- NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
- (2020) Ralf Kircheis et al. Frontiers in Immunology
- An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis
- (2020) Yili Liu et al. CYTOKINE
- Interleukin-18 in Health and Disease
- (2019) Koubun Yasuda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
- (2019) Juliane Medler et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
- (2019) Kam-Leung Siu et al. FASEB JOURNAL
- Immunoregulatory Functions of the IL-12 Family of Cytokines in Antiviral Systems
- (2019) Yifei Guo et al. Viruses-Basel
- Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker
- (2019) Abdalla Sheikh et al. Frontiers in Immunology
- Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis
- (2018) Carlos Castaño-Rodriguez et al. mBio
- Unique Action of Interleukin-18 on T Cells and Other Immune Cells
- (2018) Kenji Nakanishi Frontiers in Immunology
- A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway
- (2018) Emmy Van Quickelberghe et al. Scientific Data
- Interleukin-7 Availability Is Maintained by a Hematopoietic Cytokine Sink Comprising Innate Lymphoid Cells and T Cells
- (2017) Christopher E. Martin et al. IMMUNITY
- IL-17 Signaling: The Yin and the Yang
- (2017) Nilesh Amatya et al. TRENDS IN IMMUNOLOGY
- The Anti-allergic Cromones: Past, Present, and Future
- (2017) Ajantha Sinniah et al. Frontiers in Pharmacology
- Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome
- (2016) Roshell Muir et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-17A Is Associated With Alveolar Inflammation and Poor Outcomes in Acute Respiratory Distress Syndrome
- (2016) Carmen Mikacenic et al. CRITICAL CARE MEDICINE
- A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
- (2016) Elizabeth A. McKie et al. PLoS One
- IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
- (2016) Jeroen Slaats et al. PLoS Pathogens
- VSEARCH: a versatile open source tool for metagenomics
- (2016) Torbjørn Rognes et al. PeerJ
- Effect of Targeting Inflammation With Salsalate
- (2016) Thomas H. Hauser et al. JAMA Cardiology
- How Low Cholesterol Is Good for Anti-viral Immunity
- (2015) Luke A.J. O’Neill CELL
- The immune suppressive function of transforming growth factor-β(TGF-β) in human diseases
- (2015) Jingyi Sheng et al. GROWTH FACTORS
- Type I IFNs and IL-18 Regulate the Antiviral Response of Primary Human γδ T Cells against Dendritic Cells Infected with Dengue Virus
- (2015) Chen-Yu Tsai et al. JOURNAL OF IMMUNOLOGY
- Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
- (2015) Hin Chu et al. JOURNAL OF INFECTIOUS DISEASES
- The role of Th17 and Treg responses in the pathogenesis of RSV infection
- (2015) Thomas C. Mangodt et al. PEDIATRIC RESEARCH
- BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity
- (2014) Y. Cao et al. CANCER RESEARCH
- Crucial Roles of Interleukin-7 in the Development of T Follicular Helper Cells and in the Induction of Humoral Immunity
- (2014) Y. B. Seo et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
- (2014) Jose L. Nieto-Torres et al. PLoS Pathogens
- HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway
- (2013) Ryusho Kariya et al. CANCER LETTERS
- Cytokine synergy: An underappreciated contributor to innate anti-viral immunity
- (2013) Eric Bartee et al. CYTOKINE
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages
- (2012) Ashish Bhattacharjee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Anti-viral CD8 T cells and the cytokines that they love
- (2012) Maureen A. Cox et al. VIROLOGY
- Seeing Is Believing: Illuminating the Source ofIn VivoInterleukin-7
- (2011) Grace Yoonhee Kim et al. Immune Network
- Viral proteins function as ion channels
- (2010) Kai Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Search and clustering orders of magnitude faster than BLAST
- (2010) Robert C. Edgar BIOINFORMATICS
- Interleukin-7 promotes the survival of human CD4+effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway
- (2010) Nizar Chetoui et al. IMMUNOLOGY
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
- (2010) P. M. Miettunen et al. RHEUMATOLOGY
- An overview of IL-7 biology and its use in immunotherapy
- (2009) Nahed ElKassar et al. Journal of Immunotoxicology
- Cytokines Involved in Interferon-γ Production by Human Macrophages
- (2009) Cory M. Robinson et al. Journal of Innate Immunity
- Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1–TNFR2 cooperation
- (2009) A Wicovsky et al. ONCOGENE
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
- (2008) Allison B. Goldfine et al. CTS-Clinical and Translational Science
- An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells
- (2008) Md. Zahidunnabi Dewan et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now